Nektar Therapeutics Capital Leases, Balance Sheet, Assets by Major Class, Net
Nektar Therapeutics (NKTR) had Capital Leases, Balance Sheet, Assets by Major Class, Net of $7.40 million as of 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesBalanceSheetAssetsByMajorClassNet · last filed 2017-03-01
- 2016-12-31: Capital Leases, Balance Sheet, Assets by Major Class, Net $7.40M.
- 2015-12-31: Capital Leases, Balance Sheet, Assets by Major Class, Net $3.20M.
- 2014-12-31: Capital Leases, Balance Sheet, Assets by Major Class, Net $1.20M.
- 2013-12-31: Capital Leases, Balance Sheet, Assets by Major Class, Net $1.00M.
| Period end | Capital Leases, Balance Sheet, Assets by Major Class, Net | Capital Leases, Balance Sheet, Assets by Major Class, Net as first filed |
|---|---|---|
| 2016-12-31 | $7.40M 10-K · filed 2017-03-01 | |
| 2015-12-31 | $3.20M 10-K · filed 2017-03-01 | |
| 2014-12-31 | $1.20M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $1.00M 10-K · filed 2015-02-26 | |
| 2012-12-31 | $1.40M 10-K · filed 2014-02-27 | $1.43M 10-K · filed 2013-03-01 |
| 2011-12-31 | $1.85M 10-K · filed 2013-03-01 | |
| 2010-12-31 | $2.26M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |